Skip to main content
. Author manuscript; available in PMC: 2018 Jan 22.
Published in final edited form as: J Alzheimers Dis. 2017;58(2):401–411. doi: 10.3233/JAD-160965

Table 5b.

Summary of the VABS-II Total Score (mITT Population)

VABS-II Score Placebo
(N=6)
ELND005 250 mg BID
(N=12)
ELND005 250 mg QD
(N=4)

Baseline
 Mean (SD) 682.3 (60.9) 660.5 (49.1) 690.0 (31.8)
 Median 687.0 666.0 691.0
 Range 597.0–775.0 550.0–736.0 652.0–726.0

Week 4
 Mean (SD) 674.3 (48.9) 672.6 (53.7) 683.3 (32.0)
 Median 689.5 659.5 681.5
 Range 594.0–716.0 565.0–749.0 650.0–720.0

Week 4 CFB
 Mean (SD) −8.0 (26.0) 12.1 (31.2) −6.8 (32.7)
 Median 0.5 12.5 3.0
 Range −59.0 – 13.0 −25.0–82.0 −53–20.0